Response to treatment with pinaverium bromide in a group of patients with irritable bowel syndrome and several degrees of neurosis;Respuesta al tratamiento con bromuro de pinaverio en un grupo de pacientes con síndrome de colon irritable y diversos grados de neurosis

Medicina Interna de Mexico

Volumn 21, Issue 6, 2005, Pages 426-430

  Magallán, Alfredo Rodríguez ^a   Huerta, Leticia Ascencio ^a   Gómez, José Trinidad Altamirano ^a  

^a HOSPITAL JUÁREZ DE MÉXICO   (Mexico)

Author keywords

Anxiety; Depression; Irritable bowel disease; Neurosis; Pinaverium bromide

Indexed keywords

PINAVERIUM BROMIDE;

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; IRRITABLE COLON; LONGITUDINAL STUDY; MALE; NEUROSIS; PROSPECTIVE STUDY; TREATMENT RESPONSE;

EID: 35348849036     PISSN: 01864866     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Drossman LA, Li Z, Andruzzi E, et al. US householders survey of functional gastrointestinal disorders. Prevalence, sociodemography and health impact. Dig Dis Sci 1993;38:1569-80.
2. Mitehell CM, Drossman DA. Survell of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology 1987;92:128-84.
3. O'Keefe EA, Talley NJ, Zinsmeister AR, et al. Bowel disorders impair fuctional status and quality of life in the elderly: a population based study. Am J Gastroenterol 1995:50:184-9.
4. Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, Romell. A multinational consensus document on fuctional gastroentestinal disorders. Gut 1999;45(Suppl 2):111-8.
5. Whitehead WE, Holtkotter B, Enck P, Holmes K, Anthony J. Tolerance for rectosig moid distention in irritable bowel syndrome. Gastroenterol 1990;98:1187-92.
6. Gershon MD. Review article: roles played by 5-hidroxytryptamine in the physiology of the bowel. Aliment Pharmacol Ther 1999;13:15-30.
7. Whitehead WE, Bosmajian L, Zonderman A, et al. Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterology 1988;95:709-14.
8. Welch GW, Hillman LC, Pomare EW. Psychoneurotic symptomatology in the irritable bowel syndrome: a study of reporters and non reporters. Br Med J 1985;291:1382-4.
9. Drossman DA, Mckee DC, Sandler RS, et al. Psychosocial factors in the irritable bowel syndrome. Gastroenterology 1988;95:701-8.
10. Blauchard EB. The role of anxiety and depression in the irritable bowel syndrome. Behav Res Ther 1990;28:401-95.
11. Koloski NA, Talley NJ, Boyce PM. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia and psychosocial factors. Am J Gastroenterol 2001;96:1340-9.
12. Mayer EA, Naliboff B, Lee D, Munakata J, Chang I. Gender-related differences in functional gastrointestinal disorders. Aliment Pharmacol Ther 1999;13(Suppl 2):65-69.
13. Gear RW, Miaskowki C, Gordon N, Paul S, Heller P, Levin K. Opioids produce significantly greater analgesia in women than in men. Nature Med 1995;2:1248-50.
14. Jackson NA, Houghton LA, Whowell PJ. The menstrual cycle affects rectal visceral sensity in patients with irritable bowel syndrome but not in healthy volunteers. Gastroenterol 1997;112:A1132.
15. Drossman DA, Liz MA, Loserman J, et al. Health status by gastrointestinal diagnosis and abuse history. Gastroenterology 1996;999:1007.
16. Talley NJ, Fett SL, Zinsmeister AR, et al. Gastrointestinal tract symptoms and self-report abuse: a population based study. Gastroenterology 1994;107:1040-9.
17. Ferom O, Dessy C, Christen M, Godfraind T. Importance of the L-type calcium channel pathway in the process of internal calcium stores refilling in intestinal smooth muscle (abstr). Gastroenterology 1995;108:A598.
18. Chrsiten MO. Pinaverium bromide: a calcium antagonist with selectivity for the gastrointestinal tract. Today's Therapeutic Trend 1995;13(2):47-62.
19. Farraway L, Malysz J, Christen M, Huizinga J. Action of pinaverium bromide on action potential generation in circular and longitudinal colonic smooth muscle (abstr). Gastroenterology 1993;104A:506
20. Poynard T, Naveau S, Mory B, Chaput J. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 1994;8:499-510.
21. Awad R, Cordova VH, Dibildox M, et al. Reduction of postprandial motility by pinaverium bromide a calcium channel blocker acting selectively on the gastrointestinal tract in patients with irritable bowel syndrome. Acta Gastroenterol Latinoam 1997;27(4):247-51.
22. Fioramenti J, Christen M, Dupre I, Bueno L. Action of the calcium channel blocker pinaverium bromide on the CCK-mediated colonic motor response to a meal in rats (abstr). Gastroenterology 1995;108A:598.
23. Jule Y, Christen M. Pinaverium bromide inhibition of substance-P induced desen-dind activation in the guinea-pig distal colon (abstr). Gastroenterology 1995;108A:624.
24. Locke GR, Weaver AL, Melton LJ, Talley NJ. Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested cases control study. Am J Gastroenterol 2004;99:350-7.